GLSI Greenwich Lifesciences Inc

USD 20.00 -0.32 -1.574803
Icon

Greenwich Lifesciences Inc (GLSI) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 20.00

-0.32 (-1.57)%

USD 0.20B

0.04M

N/A

N/A

Icon

GLSI

Greenwich Lifesciences Inc (USD)
COMMON STOCK | NSD
USD 20.00
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.20B

N/A

USD 20.00

Greenwich Lifesciences Inc (GLSI) Stock Forecast

N/A

Based on the Greenwich Lifesciences Inc stock forecast from 0 analysts, the average analyst target price for Greenwich Lifesciences Inc is not available over the next 12 months. Greenwich Lifesciences Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Greenwich Lifesciences Inc is Very Bearish, which is based on 0 positive signals and 4 negative signals. At the last closing, Greenwich Lifesciences Inc’s stock price was USD 20.00. Greenwich Lifesciences Inc’s stock price has changed by +8.81% over the past week, +60.00% over the past month and +44.61% over the last year.

No recent analyst target price found for Greenwich Lifesciences Inc
No recent average analyst rating found for Greenwich Lifesciences Inc

Company Overview Greenwich Lifesciences Inc

Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which is in Phase III clinical tr...Read More

Building 14, Stafford, TX, United States, 77477

3

December

USD

USA

Adjusted Closing Price for Greenwich Lifesciences Inc (GLSI)

Loading...

Unadjusted Closing Price for Greenwich Lifesciences Inc (GLSI)

Loading...

Share Trading Volume for Greenwich Lifesciences Inc Shares

Loading...

Compare Performance of Greenwich Lifesciences Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for GLSI

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Greenwich Lifesciences Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc -1.14 (-0.27%) USD107.38B 29.93 21.06

ETFs Containing GLSI

Symbol Name GLSI's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Greenwich Lifesciences Inc (GLSI) Stock

Stock Target Advisor's fundamental analysis for Greenwich Lifesciences Inc's stock is Very Bearish.

Unfortunately we do not have enough data on GLSI's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on GLSI's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on GLSI's stock to indicate if its overvalued.

The last closing price of GLSI's stock was USD 20.00.

The most recent market capitalization for GLSI is USD 0.20B.

Unfortunately we do not have enough analyst data on GLSI's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Greenwich Lifesciences Inc's stock.

As per our most recent records Greenwich Lifesciences Inc has 3 Employees.

Greenwich Lifesciences Inc's registered address is Building 14, Stafford, TX, United States, 77477. You can get more information about it from Greenwich Lifesciences Inc's website at https://greenwichlifesciences.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...